Cardiac Arrhythmias in Pediatric Emergency Department

September 13, 2026 updated by: Hossam Hassan Abdel-Kader Hassan, Assiut University

Incidence and Outcome of Cardiac Arrhythmias Among Children in the Emergency Department at Assiut University Children Hospital

This cross-sectional study aims to determine the incidence, clinical presentation, and outcome of cardiac arrhythmias among children presenting to the Emergency Department of Assiut University Children Hospital.

Study Overview

Status

Not yet recruiting

Detailed Description

Cardiac arrhythmias are a significant concern in the pediatric emergency setting. This observational study will include children aged 1 month to 18 years presenting with symptoms suggestive of arrhythmia (palpitation, chest pain, syncope, dyspnea, or respiratory distress).

All participants will undergo full history, clinical examination, 12-lead ECG, and additional investigations as indicated (echocardiography, Holter, laboratory tests). Incidence of different arrhythmia types, clinical picture, and short-term outcomes will be recorded.

Study Type

Observational

Enrollment (Estimated)

73

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children aged 1 month to 18 years presenting to the Emergency Department of Assiut University Children Hospital with symptoms suggestive of cardiac arrhythmia.

Description

Inclusion Criteria:

  • Age from 1 month to 18 years
  • Presenting with palpitation, chest pain, syncope, dyspnea, or respiratory distress
  • Written informed consent from parents or legal guardians

Exclusion Criteria:

  • Age below 1 month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Single cohort: Children presenting to pediatric ED
Children aged 1 month to 18 years presenting to the Emergency Department with symptoms suggestive of cardiac arrhythmia who will undergo ECG and clinical assessment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of cardiac arrhythmias
Time Frame: Baseline
Proportion of children presenting to the pediatric emergency department who are diagnosed with cardiac arrhythmia based on 12-lead ECG.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Types of arrhythmias
Time Frame: Baseline
Proportion of specific arrhythmia types (sinus tachycardia, supraventricular tachycardia, ventricular tachycardia, bradyarrhythmias, premature beats, and others) among diagnosed cases.
Baseline
Need for PICU admission
Time Frame: Baseline
Proportion of children with cardiac arrhythmia who require admission to the pediatric intensive care unit.
Baseline
Need for cardioversion
Time Frame: Baseline
Proportion of children who require electrical or pharmacological cardioversion.
Baseline
Mortality
Time Frame: At 30 days
Proportion of children with cardiac arrhythmia who die during the emergency department visit or hospital stay.
At 30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ghada O Elsedfy, prof, pediatrics Department, Assiut University Hospitals

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 13, 2026

Primary Completion (Estimated)

September 13, 2027

Study Completion (Estimated)

February 25, 2028

Study Registration Dates

First Submitted

September 13, 2026

First Submitted That Met QC Criteria

September 13, 2026

First Posted (Actual)

September 17, 2026

Study Record Updates

Last Update Posted (Actual)

September 17, 2026

Last Update Submitted That Met QC Criteria

September 13, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe